オリゴヌクレオチド合成の世界市場2019-2023

LINEで送る

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY END-USER

Market segmentation by end-user

Comparison by end-user

Pharmaceutical and biotechnology companies – Market size and forecast

2018-2023

Research and academic institutes – Market size and forecast 2018-2023

Diagnostic laboratories – Market size and forecast 2018-2023

Hospitals – Market size and forecast 2018-2023

Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Increasing focus on R&D of new oligonucleotide therapeutics

Strategic collaborations and partnerships for oligonucleotide drug discovery

and development

Rise in demand for low-cost and high-throughput oligonucleotide synthesis

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Agilent Technologies Inc.

Danaher Corp.

General Electric Co.

GenScript Biotech Corp.

Kaneka Corp.

Merck KGaA

Nitto Denko Corp.

QIAGEN NV

Sarepta Therapeutics Inc.

Thermo Fisher Scientific Inc.

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Product overview

Exhibit 02: Global healthcare market

Exhibit 03: Segments of global healthcare market

Exhibit 04: Market characteristics

Exhibit 05: Market segments

Exhibit 06: Market definition – Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Five forces analysis 2018

Exhibit 11: Five forces analysis 2023

Exhibit 12: Bargaining power of buyers

Exhibit 13: Bargaining power of suppliers

Exhibit 14: Threat of new entrants

Exhibit 15: Threat of substitutes

Exhibit 16: Threat of rivalry

Exhibit 17: Market condition – Five forces 2018

Exhibit 18: End-user – Market share 2018-2023 (%)

Exhibit 19: Comparison by end-user

Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2018-2023 ($ millions)

Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2019-2023 (%)

Exhibit 22: Research and academic institutes – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Research and academic institutes – Year-over-year growth 2019-2023 (%)

Exhibit 24: Diagnostic laboratories – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Diagnostic laboratories – Year-over-year growth 2019-2023 (%)

Exhibit 26: Hospitals – Market size and forecast 2018-2023 ($ millions)

Exhibit 27: Hospitals – Year-over-year growth 2019-2023 (%)

Exhibit 28: Market opportunity by end-user

Exhibit 29: Customer landscape

Exhibit 30: Market share by geography 2018-2023 (%)

Exhibit 31: Geographic comparison

Exhibit 32: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 33: North America – Year-over-year growth 2019-2023 (%)

Exhibit 34: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 35: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 36: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 38: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 40: Key leading countries

Exhibit 41: Market opportunity

Exhibit 42: Impact of drivers and challenges

Exhibit 43: Vendor landscape

Exhibit 44: Landscape disruption

Exhibit 45: Vendors covered

Exhibit 46: Vendor classification

Exhibit 47: Market positioning of vendors

Exhibit 48: Agilent Technologies Inc. – Vendor overview

Exhibit 49: Agilent Technologies Inc. – Business segments

Exhibit 50: Agilent Technologies Inc. – Organizational developments

Exhibit 51: Agilent Technologies Inc. – Geographic focus

Exhibit 52: Agilent Technologies Inc. – Segment focus

Exhibit 53: Agilent Technologies Inc. – Key offerings

Exhibit 54: Danaher Corp. – Vendor overview

Exhibit 55: Danaher Corp. – Business segments

Exhibit 56: Danaher Corp. – Organizational developments

Exhibit 57: Danaher Corp. – Geographic focus

Exhibit 58: Danaher Corp. – Segment focus

Exhibit 59: Danaher Corp. – Key offerings

Exhibit 60: General Electric Co. – Vendor overview

Exhibit 61: General Electric Co. – Business segments

Exhibit 62: General Electric Co. – Organizational developments

Exhibit 63: General Electric Co. – Geographic focus

Exhibit 64: General Electric Co. – Segment focus

Exhibit 65: General Electric Co. – Key offerings

Exhibit 66: GenScript Biotech Corp. – Vendor overview

Exhibit 67: GenScript Biotech Corp. – Business segments

Exhibit 68: GenScript Biotech Corp. – Organizational developments

Exhibit 69: GenScript Biotech Corp. – Geographic focus

Exhibit 70: GenScript Biotech Corp. – Segment focus

Exhibit 71: GenScript Biotech Corp. – Key offerings

Exhibit 72: Kaneka Corp. – Vendor overview

Exhibit 73: Kaneka Corp. – Business segments

Exhibit 74: Kaneka Corp. – Organizational developments

Exhibit 75: Kaneka Corp. – Geographic focus

Exhibit 76: Kaneka Corp. – Segment focus

Exhibit 77: Kaneka Corp. – Key offerings

Exhibit 78: Merck KGaA – Vendor overview

Exhibit 79: Merck KGaA – Business segments

Exhibit 80: Merck KGaA – Organizational developments

Exhibit 81: Merck KGaA – Geographic focus

Exhibit 82: Merck KGaA – Segment focus

Exhibit 83: Merck KGaA – Key offerings

Exhibit 84: Nitto Denko Corp. – Vendor overview

Exhibit 85: Nitto Denko Corp. – Business segments

Exhibit 86: Nitto Denko Corp. – Organizational developments

Exhibit 87: Nitto Denko Corp. – Geographic focus

Exhibit 88: Nitto Denko Corp. – Segment focus

Exhibit 89: Nitto Denko Corp. – Key offerings

Exhibit 90: QIAGEN NV – Vendor overview

Exhibit 91: QIAGEN NV – Product segments

Exhibit 92: QIAGEN NV – Organizational developments

Exhibit 93: QIAGEN NV – Geographic focus

Exhibit 94: QIAGEN NV – Segment focus

Exhibit 95: QIAGEN NV – Key offerings

Exhibit 96: Sarepta Therapeutics Inc. – Vendor overview

Exhibit 97: Sarepta Therapeutics Inc. – Product segments

Exhibit 98: Sarepta Therapeutics Inc. – Organizational developments

Exhibit 99: Sarepta Therapeutics Inc. – Key offerings

Exhibit 100: Thermo Fisher Scientific Inc. – Vendor overview

Exhibit 101: Thermo Fisher Scientific Inc. – Business segments

Exhibit 102: Thermo Fisher Scientific Inc. – Organizational developments

Exhibit 103: Thermo Fisher Scientific Inc. – Geographic focus

Exhibit 104: Thermo Fisher Scientific Inc. – Segment focus

Exhibit 105: Thermo Fisher Scientific Inc. – Key offerings

Exhibit 106: Validation techniques employed for market sizing

Exhibit 107: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様